Crezone-TZ 1.125 Injection
Marketer
Crepis Pharma
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Crezone-TZ 1.125 Injection
Tazicef 1.125 Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and proliferation. Administration must be overseen by a medical professional; strict adherence to the prescribed dosage schedule is crucial, completing the entire course even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate emergency medical care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Crezone-TZ 1.125 Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Crezone-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Crezone-TZ 1.125 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Crezone-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Crezone-TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Crezone-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, the active components of Crezone-TZ 1.125 Injection, work synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Crezone-TZ 1.125 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Crezone-TZ 1.125 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Crezone-TZ 1.125 Injection necessitates careful consideration during lactation. Nursing mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administration of Crezone-TZ 1.125 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Crezone-TZ 1.125 Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Crezone-TZ 1.125 Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Crezone-TZ 1.125 Injection is unnecessary in individuals with mild or moderately compromised liver function.
What if you forget to take Crezone-TZ 1.125 Injection :
Omit a Crezone-TZ 1.125 Injection dose? Seek your physician's advice.
Facts to Know About Crezone-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently